A study conducted at the University College London School of Pharmacy has revealed a link between the use of drugs for erectile dysfunction and a lower risk of dementia. The study, which lasted over five years, included nearly 270,000 men with an average age of 58 who were diagnosed with erectile dysfunction and did not have cognitive problems at the start of the study. About 55% of the men took drugs such as Viagra, Cialis, and others that work by dilating blood vessels.
The research findings showed that among men who were treated with drugs for erectile dysfunction, the rate of dementia cases was 120% lower compared to those who were not treated with drugs. Those who received the most medication prescriptions, taking a larger amount of the medication per month in the correct dose, were at the least risk of developing dementia. However, the researchers emphasized that these findings do not prove that the drugs themselves reduce the risk of dementia but may mark a new research direction in which the mechanisms behind dementia and possible effects on brain health will be examined.
Dr. Kobi Reisman, a specialist in urology and sexual therapy and director of European Academy of Sexual Medicine explained that previous laboratory studies have shown that Viagra has an anti-inflammatory effect and can prevent deposits from forming in brain cells that lead to Alzheimer’s disease. He also pointed out that these drugs have antioxidant properties that can positively affect blood vessels. However, he emphasized that Viagra is not a treatment for Alzheimer’s disease but more research is needed to understand this mechanism in detail.
In conclusion, while these findings don’t prove that Viagra or other ED medications reduce dementia risk directly, they suggest further investigation into how blood vessel-dilating drugs affect brain health could be beneficial for future treatments and interventions. It highlights a clear connection between erectile dysfunction and human health with implications for conditions such as heart disease.